Pulmonary Complications of HIV Infection

AIDS and Other Manifestations of HIV Infection

Volumn , Issue , 2004, Pages 407-421

  Wagner, Krystn R ^a   Chaisson, Richard E ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942856106     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012764051-8/50018-4     Document Type: Chapter

References (69)

1. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000, 30(suppl 1):S5-S14.
2. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990, 32:161-165. Multicenter AIDS Cohort Study Group.
3. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Joy JF Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991, 4:770-776.
4. Moore RD, Chaisson RE Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996, 124:633-642.
5. Stansell JD, Osmond DH, Charlebois E, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Am J Respir Crit Care Med 1997, 155:60-66. Pulmonary Complications of HIV Infection Study Group.
6. Kaplan JE, Hanson DL, Jones JL, et al. Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents. AIDS 2001, 15:1831-1836.
7. Stover DE, Greeno RA, Gagliardi AJ The use of a simple exercise test for the diagnosis of Pneumocystis carinii. pneumonia in patients with AIDS. Am Rev Respir Dis 1989, 139:1343-1346.
8. Chouaid C, Maillard D, Houssett B, et al. Cost effectiveness of noninvasive oxygen saturation measurement during exercise for the diagnosis of Pneumocystis carinii pneumonia. Am Rev Respir Dis 1993, 147:1360-1363.
9. Opravil M, Marincek B, Fuchs WA, et al. Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol 1994, 7:39-45.
10. Boldt MJ, Bai TR Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. Chest 1997, 111:1187-1192.
11. Huang L, Hecht FM, Stansell JD, et al. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful?. Am J Respir Crit Care Med 1995, 151:1866-1871.
12. Kovacs JA, Gill VJ, Meshnick S, Masur H New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001, 286(19):2450-2460.
13. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990, 323:1500-1504. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia.
14. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, et al. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999, 354:1347-1351.
15. Kazanjian P, Locke AB, Hossler PA, et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998, 12:873-878.
16. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. MMWR 2002, 51:1-52. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
17. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995, 333:845-851. Pulmonary Complications of HIV Infection Study Group.
18. Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995, 152:1309-1315.
19. Gebo K, Moore RD, Keruly JC, Chaisson RE Risk factors for pneumococcal disease in HIV infection. J Infect Dis 1996, 173:857-862.
20. Breiman RF, Keller DW, Phelan MA, et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med 2000, 160:2633.
21. French N, Nakiyingi J, Carpenter LM, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000, 355(9221):2106-2111. Jun 17.
22. Tasker SA, Wallace MR, Rubins JB, et al. Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type 1: clinical, immunologic, and virologic responses. Clin Infect Dis 2002, 34:813-821.
23. Javaly K, Horowitz HW, Wormser GP Nocardiosis in patients with human immunodeficiency virus infection: Report of 2 cases and review of the literature. Medicine (Baltimore) 1992, 71:128-138.
24. Rodriguez JL, Barrio JL, Pitchenik AE Pulmonary nocardiosis in the acquired immunodeficiency syndrome: Diagnosis with bronchoalveolar lavage and treatment with non-sulphur containing drugs. Chest 1986, 90:912-914.
25. Kramer MR, Uttamchandani RB The radiographic appearance of pulmonary, nocardiosis associated with AIDS. Chest 1990, 98:382-385.
26. Parmentier L, Salmon-Ceron D, Boiron P, Paul G, Guez T, Dupont B, Sicard D Pueumopathy and kidney abscess due to Nocardia farcinica in an HIV-infected patient. AIDS 1992, 6:891-893.
27. Filice GA, Simpson GL Management of Nocardia infections. Current Clinical Topics in Infectious Disease 1988, 5:49-65. McGraw-Hill, New York. I.S. Remington, M. Swartz (Eds.).
28. Wilson JP, Turner HR, Kirchner KA, Chapinan SW Nocardial infections in renal transplant recipients. Medicine (Baltimore) 1989, 68:3857.
29. Saimies JH, Hathawav BN, Echols RM, Veazey JM, Pilon VA Lung abscess due to Corynebacteriuin equi-Report of the first case in a patient with acquired immune deficiency syndrome. Am J Med 1986, 80:685-688.
30. MacGregor JH, Samuelson WM, Sane DC, Godwin JD Opportunistic lung infection caused by Rhodococcus (Corynebacterium) equi. Radiology 1986, 160:83.
31. Weingarten JS, Huang DY, Jackman JD Rhodococcus equi pneumonia. An unusual early manifestation of the acquired immunodeficiency syndrome (AIDS). Chest 1988, 94:195-196.
32. Bishopric GA, d'Agay MF, Schlemmer B, Sarfati E, Brocheriou C Pulmonary pseudotumor due to Corynebacterium equi in a patient with the acquired immunodeficiency I syndrome. Thorax 1988, 43:486-487.
33. Harvey RL, Sunstruin JC Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 1991, 13:139-145.
34. Emmons W, Reichwein B, Winslow DL Rhodococcus equi infection in the patient with AIDS: Literature review and report of an unusual case. Rev Infect Dis 1991, 13:91-96.
35. Willsie-Ediner SK, Stanford JF, Salzman GA, Bamberger DM Spectrum of disease caused by Rhodococcus equi in human immunodeficiencv virus infection. Report of a case and review of the literature. Can J Infect Dis 1990, 1:101-107.
36. Levine SJ, White DA, Fels AO The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with the human immunodeficiency virus. Am Rev Respir Dis 1990, 141:89-93.
37. Kielhofner M, Atmar RL, Hamill RJ, Musher DM Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992, 14:403-411.
38. Baron AD, Hollander H Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dir 1993, 148(4):992-996. Pt 1.
39. Dropulic LK, Leslie JM, Eldred LJ, et al. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis 1995, 171(4):930-937.
40. Mundy LM, Auwaerter PG, Oldach D, et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995, 152(4):1309-1315. Pt 1.
41. Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DF Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987, 156:998-1002.
42. Jacobs JL, Gold JWM, Murray HW, et al. Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985, 102:186.
43. Amador C, Chiner E, Calpe JL, Ortiz de la Table V, Martinez C, Pasquan F Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev Infect Dis 1991, 13:771-772. (Letter).
44. Decker GR, Lavelle JP, Kumar PN, Pierce PF Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev Infect Dis 1991, 13:1250-1251. (Letter).
45. Ng VL, Boggs J.M, York MK, Golden JA, Hollander H, Hadley WK Recovery of Bordetella bronchiseptica from patients with AIDS. Clin Infect Dis 1992, 15:376-377.
46. Caron F, Bora-Lebas F, Boiron P, et al. Streptomyces (S) sp. as a cause of nodular pneumonia in an HIV infected patient?. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy 1992, (Abstract 1093).
47. Murray JF, Felton CP, Gray SM, Gottlieb MS, Hopewell PC, Stover DE, Teirstein AS Pulmonary complications of the acquired immunodeficiency syndrome. N Engl J Med 1984, 310:1682-1688.
48. Khardofi N, Haron E, Rolston K Legionella micdadei pneumonia in the acquired immune deficiency syndrome. Am J Med 1987, 83:600-601. (Letter).
49. Mirich D, Gray R, Hyland R Legionella lung cavitation. J Can Assoc Radiol 1990, 41:100-102.
50. Havlir DV, Barnes PF Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999, 340:367-373. Feb 4.
51. Colebunders RL, Ryder RW, Nzilambi N, et al. HIV infection in patients with tuberculosis in Kinshasha, Zaire. Am Rev Respir Dis 1989, 139:1082-1085.
52. Pitchenik AE, Rubinson HA The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985, 131:383-386.
53. Pedro-Botet J, Gutierrez J, Miralles R, Coll J, Rubies-Prat J Pulmonary tuberculosis in HIV-infected patients with normal chest radiographs. AIDS 1992, 6:91-93.
54. Theuer CP, Hopewell PC, Elias D, et al. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990, 162:8-12.
55. Sunderam G, McDonald RJ, Maniatis T, et al. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA 1996, 256:362-366.
56. Rieder HL, Snider DE, Canthen GM Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990, 141:347-351.
57. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987, 136:570-574.
58. Shafer RW, Kim DS, Weiss JP, Quale JM Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991, 70:384-396.
59. Packer SJ, Cesario T, William JH Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients. Ann Intern Med 1988, 109(5):389-393. Sep 1.
60. Levine B, Chaisson RE Mycobacterium kansasii: A cause of treatable pulmonary disease in patients with advanced human immunodeficiency virus infection. Ann Intern Med 1991, 114:861-868.
61. Carpenter JL, Parks JM Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Rev Infect Dis 1991, 13:789-796.
62. McKinsey DS, Wheat LJ, Cloud GA, et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1999, 28:1049-1056.
63. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group. Ann Intern Med 1993, 119:28-35.
64. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Ann Intern Med 2000, 133:676-686. Mycoses Study Group.
65. Wallace JM, Lim R, Browdy BL, et al. Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Chest 1998, 114:131-137. Pulmonary Complications of HIV Infection Study Group.
66. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002, 347:408-415.
67. Kolber MA, Gabr AH, De La Rosa A, et al. Genotypic analysis of plasma HIV-1 RNA after influenza vaccination of patients with previously undetectable viral loads. AIDS 2002, 16:537-542.
68. Tamm M, Reichenberger F, McGandy CE, et al. Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage. Am J Respir Crit Care Med 1998, 157:458-463.
69. Ray P, Antoine M, Mary-Krause M, et al. AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med 1998, 158:1221-1229.